Ozempic
Weight Loss Treatment
- GLP-1 injection taken once a week
- MHRA approved for weight loss
- Up to 5 - 10% weight loss
Treatment plan starts from
£229.00 £199.00/month
Controlled Blood Sugar
Appetite Suppression
Improved Metabolic Profile
What is Ozempic
What makes Ozempic unique:
Dual Benefit: It not only helps manage blood sugar but also has been shown to reduce the risk of cardiovascular death, heart attack, and stroke in adults
With GLP-1 Medication
Diet & Exercise alone
How does Ozempic work?
Ozempic (Semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a naturally occurring hormone that helps regulate insulin production, slows down digestion, increases satiety etc. Overall, it works by acting on your body’s natural systems to regulate blood sugar levels more effectively by mimicking the effects of GLP-1 in the body.*
It impacts different organs and weight loss which can be a common side effect.*
Brain
Appetite
suppression
Systemic effects
Improved blood
sugar control
Stomach
Slowed gastric
emptying
Pancreas
Enhanced insulin
secretion
Brain
Appetite
suppression
Systemic effects
Improved blood
sugar control
Stomach
Slowed gastric
emptying
Pancreas
Enhanced insulin
secretion
Ozempic: Proven to significantly lower blood sugar and A1C
A1C levels decrease below
7%*
Reduced risk of cardiovascular disease*
Embarking on the Journey
to Healthier Living
FAQ
Your Ozempic Questions Answered: Explore Our FAQ Section
You can buy Ozempic (semaglutide) online from Priman Weight Loss Clinic with next day UK delivery. It is available by prescription type 2 diabetes and off-label for weight management under specific criteria set by National Institute for Health and Care Excellence (NICE). To buy Ozempic get assessed by a healthcare professional to see if this weight loss pen is right for you. If you meet the criteria, your doctor will provide you with a prescription to buy Ozempic.
Ozempic comes in different strengths to suit individual needs. As with most medications, the cost can vary depending on the dosage prescribed by your doctor. We at Priman is committed to offering Ozempic at competitive rates to help you achieve your weight loss goals.
- The most common side effects include nausea, vomiting, diarrhoea, decreased appetite, indigestion, constipation, stomach discomfort, and fatigue.
- In rare cases, more serious side effects can occur, such as gallbladder problems, severe inflammation of the pancreas, vision changes, or kidney injury. Allergic reactions are also uncommon.
It is a self-injected medication typically taken once a week. Your healthcare professional will prescribe the dosage depending on your clinical assessment and guide on injection sites (stomach, thigh, upper arm). It comes in a prefilled pen for easy use.
Ozempic is currently approved for adults with type 2 diabetes to manage blood sugar. Talk to your healthcare professional to check if Ozempic is the right treatment for you.
Ozempic pens come in two storage stages:
- Unused: Keep refrigerated (36°F to 46°F) until first use.
- In Use: Store for up to 56 days at room temperature (59°F to 86°F) or refrigerate.
- Weight Loss
- 2 min read
Ozempic (semaglutide) has been a game-changer for many struggling with weight management....
- Weight Loss
- 3 min read
Ozempic, a medication used to treat type 2 diabetes, has gained popularity...
- Weight Loss
- 3 min read
Ozempic (semaglutide) weight loss injection has become a popular name in weight...
- Hair Loss
- 3 min read
Ozempic (semaglutide) has taken the weight management world by storm. This injectable...
- Weight Loss
- 2 min read
Ozempic (semaglutide) has become a popular medication for type 2 diabetes and...
*British Heart Foundation (2024) Weight loss drugs could have cardiovascular benefits, new research shows, British Heart Foundation. Available at: https://www.bhf.org.uk/what-we-do/news-from-the-bhf/news-archive/2024/may/weight-loss-drugs-could-have-cardiovascular-benefits-new-research-shows
*Ghusn, W. et al. (2022) “Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity,” JAMA network open, 5(9), p. e2231982. doi: 10.1001/jamanetworkopen.2022.31982.
*Healthcare products Regulatory Agency (2023) Falsified Ozempic (semaglutide) pens identified at two wholesalers in the UK, Gov.uk. Available at: https://www.gov.uk/government/news/falsified-ozempic-semaglutide-pens-identified-at-two-wholesalers-in-the-uk
*Ozempic (2024) Europa.eu. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic
